Literature DB >> 29248960

Predictors of the need for pacemaker implantation after the Cox maze IV procedure for atrial fibrillation.

Naoki Masaki1, Shunsuke Kawamoto1, Naotaka Motoyoshi1, Osamu Adachi1, Kiichiro Kumagai1, Satoshi Kawatsu1, Yukihiro Hayatsu1, Shintaro Katahira1, Katsuhiro Hosoyama1, Masatoshi Akiyama1, Yoshikatsu Saiki2.   

Abstract

PURPOSE: The Cox maze IV (CMIV) procedure is being used increasingly frequently for surgical ablation of atrial fibrillation (AF). This study aimed to identify the risk factors of the need for postoperative pacemaker implantation (PMI) after CMIV.
METHODS: Preoperative, intraoperative, and postoperative data were retrospectively collected from 67 consecutive patients who underwent CMIV at our institution; 7 (10.4%) required PMI (as a treatment of brady AF or sick sinus syndrome).
RESULTS: Patients who needed PMI tended to have lower preoperative heart rates than those who did not on a 12-lead electrocardiogram (ECG; 68.7 ± 11.6 vs. 79.1 ± 18.5 bpm, p = 0.07) and a 24-h ECG (94,772 ± 9800 vs. 109,854 ± 19,078 beats/day, p = 0.03). A multivariate analysis identified a low amplitude of the fibrillatory wave on preoperative ECG as a risk factor of PMI necessity after CMIV [odds ratio = 14.7; 95% confidence interval (CI) 1.9-324.7; p = 0.007] and internal use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs) as a negative risk factor (odds ratio = 0.16; 95% CI 0.02-0.99; p = 0.049).
CONCLUSIONS: A low amplitude of the fibrillatory wave was identified as a risk factor of PMI necessity, whereas the internal use of ACEIs/ARBs diminished the need for PMI. These factors should be considered before CMIV is performed.

Entities:  

Keywords:  Amplitude of fibrillatory wave; Angiotensin-converting enzyme inhibitor; Atrial fibrillation; Maze procedure; Pacemaker implantation

Mesh:

Year:  2017        PMID: 29248960     DOI: 10.1007/s00595-017-1614-7

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  36 in total

1.  The diagnostic importance of fibrillatory wave size.

Authors:  M THURMANN; J G JANNEY
Journal:  Circulation       Date:  1962-06       Impact factor: 29.690

2.  Relationship of atrial fibrillatory wave amplitude to left atrial size and etiology of heart disease. An old generalization re-examined.

Authors:  J Morganroth; L N Horowitz; M E Josephson; J A Kastor
Journal:  Am Heart J       Date:  1979-02       Impact factor: 4.749

Review 3.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

4.  Can we change the operative criteria for the MAZE procedure combined with valve surgery in the era of radiofrequency devices?

Authors:  Suguru Kubota; Hiroshi Sugiki; Satoru Wakasa; Tomonori Ooka; Tsuyoshi Tachibana; Shigeyuki Sasaki; Yoshiro Matsui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

5.  Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans.

Authors:  A Goette; M Arndt; C Röcken; A Spiess; T Staack; J C Geller; C Huth; S Ansorge; H U Klein; U Lendeckel
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

6.  Incidence and predictors of pacemaker placement after surgical ablation for atrial fibrillation.

Authors:  Berhane Worku; Sang-Woo Pak; Faisal Cheema; Mark Russo; Brian Housman; Danielle Van Patten; Jessica Harris; Michael Argenziano
Journal:  Ann Thorac Surg       Date:  2011-12       Impact factor: 4.330

7.  Atrial fibrillatory wave characteristics on surface electrogram: ECG to ECG repeatability over twenty-four hours in clinically stable patients.

Authors:  Qin Xi; Alan V Sahakian; Jason Ng; Steven Swiryn
Journal:  J Cardiovasc Electrophysiol       Date:  2004-08

8.  Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Ramachandran S Vasan; Eric P Leip; Philip A Wolf; Ralph B D'Agostino; Joanne M Murabito; William B Kannel; Emelia J Benjamin
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

9.  The Maze procedure for the treatment of atrial fibrillation: a minimally invasive approach.

Authors:  Niv Ad; James L Cox
Journal:  J Card Surg       Date:  2004 May-Jun       Impact factor: 1.620

10.  Predictors and risk of pacemaker implantation after the Cox-maze IV procedure.

Authors:  Jason O Robertson; Phillip S Cuculich; Lindsey L Saint; Richard B Schuessler; Marc R Moon; Jennifer Lawton; Ralph J Damiano; Hersh S Maniar
Journal:  Ann Thorac Surg       Date:  2013-04-30       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.